US AIDS chief altered report on nevirapine safety risks

Predictors of Seizure Development in Septo-optic Dysplasia: A Retrospective Study.

Journal of child neurology·2026

Cell numbers contribute to cell fate during Ciona cardiopharyngeal mesoderm specification.

Proceedings of the National Academy of Sciences of the United States of America·2026

Sleep Disturbances in Children With Septo-Optic Dysplasia: A Retrospective Cohort Study.

Pediatric neurology·2025

Epileptic Spasms in Septo-Optic-Pituitary Dysplasia: A Retrospective Cohort Study.

Pediatric neurology·2025

Utilization of Oral Healthcare Among Uninsured Populations During the COVID-19 Pandemic in the United States.

Cureus·2025

Chaperone requirements for de novo folding of Saccharomyces cerevisiae septins.

Molecular biology of the cell·2022

How to build an AI-driven digital organism.

Nature medicine·2026

First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.

Nature medicine·2026

Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

Nature medicine·2026

Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

Nature medicine·2026

Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.

Nature medicine·2026

Type 2 diabetes prevention across the life course.

Nature medicine·2026

Biosynthesis of (+)-palitantin requires homologs of alkyl salicylaldehyde-forming enzymes without involvement of an aromatic intermediate.

Chemical science·2026

Correction: Igielska-Kalwat et al. Changes in Resveratrol Containing Phytosterol Liposomes During Model Heating. Molecules 2025, 30, 4645.

Molecules (Basel, Switzerland)·2026

Corrigendum to "Cefepime/Enmetazobactam".

Hospital pharmacy·2026

Correction: miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.

PloS one·2026

Successful Re-challenge of zongertinib following erythema multiforme-like drug eruption in a patient with HER2-mutant non-small cell lung cancer.

Respiratory medicine case reports·2026

Erratum: [Corrigendum] CDDO, a PPAR-γ ligand, inhibits TPA-induced cell migration and invasion through a PPAR-γ-independent mechanism.

Oncology letters·2026

Related Experiment Videos

US AIDS chief altered report on nevirapine safety risks

Related Concept Videos

Predictors of Seizure Development in Septo-optic Dysplasia: A Retrospective Study.

Cell numbers contribute to cell fate during Ciona cardiopharyngeal mesoderm specification.

Sleep Disturbances in Children With Septo-Optic Dysplasia: A Retrospective Cohort Study.

Epileptic Spasms in Septo-Optic-Pituitary Dysplasia: A Retrospective Cohort Study.

Utilization of Oral Healthcare Among Uninsured Populations During the COVID-19 Pandemic in the United States.

Chaperone requirements for de novo folding of Saccharomyces cerevisiae septins.

How to build an AI-driven digital organism.

First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.

Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.

Type 2 diabetes prevention across the life course.

Biosynthesis of (+)-palitantin requires homologs of alkyl salicylaldehyde-forming enzymes without involvement of an aromatic intermediate.

Correction: Igielska-Kalwat et al. Changes in Resveratrol Containing Phytosterol Liposomes During Model Heating. Molecules 2025, 30, 4645.

Corrigendum to "Cefepime/Enmetazobactam".

Correction: miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.

Successful Re-challenge of zongertinib following erythema multiforme-like drug eruption in a patient with HER2-mutant non-small cell lung cancer.

Erratum: [Corrigendum] CDDO, a PPAR-γ ligand, inhibits TPA-induced cell migration and invasion through a PPAR-γ-independent mechanism.

Related Experiment Videos

US AIDS chief altered report on nevirapine safety risks

Related Concept Videos

Related Articles